Kenvue reported a challenging second quarter of 2025, with organic sales declining 4.2% and adjusted EPS falling to $0.29 from $0.32 in the prior year, missing expectations. Despite global consumption growing year-over-year and outpacing sales across all segments, the company faced headwinds from soft allergy seasons, trade inventory fluctuations, and execution issues. Adjusted operating margin contracted 10 basis points to 22.7%, while gross margins fell 70 basis points to 60.9% due to inflation and strategic price investments. Consequently, management revised full-year 2025 guidance, projecting organic sales down low single digits and adjusted EPS between $1.00 and $1.05, citing the need for greater brand investment choicefulness and cost discipline. New Interim CEO Kirk Perry emphasized a strategic pivot to reduce 'self-induced complexity,' improve execution on core brands, and leverage a 'modern CPG playbook' to stabilize the business.
| Metric | Value | Change |
|---|---|---|
| Organic Sales Growth | -4.2% | Decline vs prior year |
| Adjusted EPS | $0.29 | Down from $0.32 prior year |
| Adjusted Operating Margin | 22.7% | Contraction of 10 bps |
| Gross Margin | 60.9% | Contraction of 70 bps |
| Global Consumption Growth | Positive | Outpaced organic sales |
Strategic Review of Alternatives: The Board has formed a strategic review committee to explore a broad range of alternatives, including optimizing the brand portfolio. This signals a willingness to make significant structural changes, such as divestitures or M&A, to unlock shareholder value. Management emphasized they are moving with 'rigor and urgency,' suggesting that no option is off the table as they seek to improve the company's growth trajectory.
Complexity Reduction and SKU Rationalization: Management identified 'self-induced complexity' as a primary inhibitor to growth. They noted that a long tail of SKUs accounts for only ~1% of sales, and 41 brands drive over 75% of sales. The strategic signal indicates a move toward pruning underperforming assets and focusing resources on the 'biggest brands, biggest countries, and biggest innovations' to improve efficiency and marketing ROI.
Adoption of a 'Modern CPG Playbook': New CEO Kirk Perry brings extensive experience from Google and Circana, emphasizing a shift to a tech-first, data-driven approach. He highlighted the need to win in e-commerce, where Kenvue is currently 'significantly underdeveloped,' and to leverage AI and data analytics. This signals a strategic pivot from traditional CPG methods to digital-first consumer engagement and execution.
Focus on Execution over Strategy: Perry explicitly stated that 'the only strategy our consumers and customers ever see is our execution.' The immediate strategic focus is on the 'zero, first, and second moments of truth'—awareness, purchase, and usage. This signals a shift away from high-level strategy formulation to rigorous operational execution, fixing supply chain disconnects, and ensuring on-shelf availability.
Consumption Growth vs. Sales Decline: A critical strategic insight is that global consumption grew while organic sales declined. This indicates that the brands retain consumer demand, but the company is failing to convert that demand into shipments due to inventory dynamics and forecasting errors. The signal suggests that fixing the supply chain and aligning with retailer inventory cycles could yield a relatively quick rebound in top-line performance once execution improves.
Significant Guidance Cut: Management revised FY2025 guidance downward, now expecting organic sales to be down low single digits and EPS between $1.00 and $1.05, down from previous expectations. This indicates that the challenges faced in Q2 are not merely temporary blips but structural issues that will persist through the year, requiring time and investment to fix.
Execution and Inventory Disconnect: The admission that organic sales fell 4.2% despite consumption growing highlights a failure in demand forecasting and inventory management. Management cited 'trade inventory fluctuations' and 'changes in shipment timing' as major drivers, suggesting a lack of control over the supply chain and an inability to capitalize on existing consumer demand.
Margin Contraction Pressure: Despite efforts to drive productivity, adjusted operating margins contracted 10 basis points, and management guided for further contraction in FY2025. Headwinds from 'strategic price investments,' fixed cost deleverage, and inflation are expected to outweigh productivity initiatives, signaling that profitability may remain under pressure in the near term.
Competitive Pressures in Key Categories: In Essential Health, specifically the mouthwash business, Kenvue is losing share in the U.S. total universe because it is 'not playing strongly enough in the fastest-growing mild alcohol-free segment.' Management noted it will 'take some time' to reverse this trend, indicating a potential lag in regaining competitiveness in a high-growth segment.
Leadership Transition Instability: While the new CEO and CFO bring experience, the company is operating with an 'Interim' CEO while simultaneously undergoing a massive strategic review and operational overhaul. This dual focus on restructuring the business and evaluating strategic alternatives (including potential breakups) could distract management and slow decision-making.
Overall: Management conveyed a sense of urgency and accountability, acknowledging the severity of the underperformance while expressing confidence in their ability to execute a turnaround. The tone shifted from defensive to proactive, with Perry and Banati admitting to execution failures and 'self-induced complexity' but insisting on a clear path to recovery through fundamental operational fixes.
Confidence: MEDIUM - While management expressed high confidence in the brand potential and their own experience to turn the business around, the significant guidance cut and admission of deep-seated operational issues (complexity, forecasting errors) tempers the near-term confidence. They are confident in the *plan* but realistic about the *current results*.
Down low single digits
$1.00 to $1.05
Neutral
Contracting vs last year
Hedging & Uncertainty: Management utilized hedging language primarily around the timeline and certainty of the recovery. Phrases like 'we believe a more muted outlook is warranted' and 'we do not expect to be fully offset' were used to temper expectations regarding margins and inflation. They also hedged on the strategic review, stating they are 'considering a broad range of potential alternatives' without committing to a specific path. However, regarding the operational issues, they were surprisingly direct, using unqualified terms like 'self-induced complexity' and 'well below expectations,' which reduces hedging in the assessment of past performance but increases it regarding future guidance.
We faced a tough quarter. And our top line results were well below expectations. - Kirk L. Perry, Interim CEO
There is a significant amount of complexity across the organization... we need to be more choiceful on where to play and how to win. - Kirk L. Perry, Interim CEO
We are not satisfied with our performance in the second quarter and the results we currently expect for the full year. - Amit Banati, Chief Financial Officer
The only strategy our consumers and customers ever see is our execution. - Kirk L. Perry, Interim CEO
We are moving with rigor and urgency to deliver the best outcome for our shareholders. - Kirk L. Perry, Interim CEO
We have created self-induced complexity that we need to fix. - Kirk L. Perry, Interim CEO
Analyst Sentiment: Analysts were skeptical but probing, focusing heavily on the feasibility of the turnaround and the specifics of the 'complexity' issue. Questions centered on the timeline for the strategic review, the necessity of divestitures (referencing P&G's history), and the disconnect between consumption and sales.
Management Responses: Management was candid about the 'self-induced' nature of the problems but deflected specific questions about the strategic review outcomes (e.g., divestitures) by emphasizing the breadth of the review. They provided detailed operational examples (e.g., e-commerce underdevelopment, media ROI) to demonstrate they have a diagnostic grasp of the issues.
Strategic Review & Complexity: Analysts asked if the strategic review would lead to divestitures similar to P&G's turnaround. Perry responded that they are looking at a 'broad range' of alternatives and that execution improvements are happening in parallel.
Consumption vs. Sales Gap: Analysts sought clarity on why sales were down while consumption was up. Management explained this was due to trade inventory fluctuations and shipment timing in China, alongside soft seasonality.
Guidance & Q3 Trends: Analysts asked about Q3 trends and the shape of the P&L. Banati noted July trends were similar to Q2 (consumption ahead of sales) and confirmed that the guidance assumes continued category softness and cautious consumer sentiment.
Kenvue is in the early stages of a necessary operational turnaround under new leadership. The core assets—iconic brands like Tylenol, Listerine, and Neutrogena—remain resilient, evidenced by consumption growth outpacing shipment declines. However, the admission of 'self-induced complexity' and the significant guidance cut highlight deep-seated execution and inventory management issues that will take time to resolve. While the strategic review offers potential upside via M&A or portfolio optimization, the near-term outlook is clouded by margin contraction and organizational restructuring. Investors should wait for tangible signs of execution improvement and stability in the organic sales trajectory before increasing exposure.
Management reported 'soft allergy and sun care seasons' in their largest markets, with allergy incidences in the U.S. hitting the 'second lowest on record.' This negatively impacted replenishment orders and seasonal stock-keeping units.
The company faced 'negative impact on top line from both trade inventory fluctuations at certain customers in the U.S.' and shipment timing changes in China, indicating that retailers are managing working capital tightly, leading to volatile order patterns.
CFO Amit Banati noted that 'the sentiment of consumers is cautious,' which has been factored into the revised guidance, suggesting a broader macro hesitation that is affecting category growth rates.